Small conjugate-based theranostic agents: an encouraging approach for cancer therapy.
about
Imaging of targeted lipid microbubbles to detect cancer cells using third harmonic generation microscopy.Visualization of drug delivery processes using AIEgensA Novel Gd-DTPA-conjugated Poly(L-γ-glutamyl-glutamine)-paclitaxel Polymeric Delivery System for Tumor Theranostics.Unraveling the Alkaline Phosphatase Inhibition, Anticancer, and Antileishmanial Potential of Coumarin-Triazolothiadiazine Hybrids: Design, Synthesis, and Molecular Docking Analysis.Cisplatin Prodrug-Conjugated Gold Nanocluster for Fluorescence Imaging and Targeted Therapy of the Breast Cancer.Pillar[5]arene-based amphiphilic supramolecular brush copolymer: fabrication, controllable self-assembly and application in self-imaging targeted drug deliveryTetraphenylethene-based highly emissive metallacage as a component of theranostic supramolecular nanoparticles.Azo-Based Fluorogenic Probes for Biosensing and Bioimaging: Recent Advances and Upcoming Challenges.Nanoparticle design strategies for enhanced anticancer therapy by exploiting the tumour microenvironment.Cellular Uptake and Photo-Cytotoxicity of a Gadolinium(III)-DOTA-Naphthalimide Complex "Clicked" to a Lipidated Tat Peptide.Oligonucleotide-based theranostic nanoparticles in cancer therapy.The rational design of a gemcitabine prodrug with AIE-based intracellular light-up characteristics for selective suppression of pancreatic cancer cells.Hypoxia-responsive nanocarriers for cancer imaging and therapy: recent approaches and future perspectives.Multifunctional Nanoparticles Self-Assembled from Small Organic Building Blocks for Biomedicine.Fluorescent chemical probes for accurate tumor diagnosis and targeting therapy.Cancer-Associated, Stimuli-Driven, Turn on Theranostics for Multimodality Imaging and Therapy.Stimuli-responsive multifunctional glyconanoparticle platforms for targeted drug delivery and cancer cell imagingSingle Near-Infrared Emissive Polymer Nanoparticles as Versatile Phototheranostics.Modulation of Intracellular Quantum Dot to Fluorescent Protein Förster Resonance Energy Transfer via Customized Ligands and Spatial Control of Donor-Acceptor Assembly.Biodegradable Core-shell Dual-Metal-Organic-Frameworks Nanotheranostic Agent for Multiple Imaging Guided Combination Cancer Therapy.Fluorogenic reaction-based prodrug conjugates as targeted cancer theranostics.Synthesis and In Vitro Characterization of Fe3+-Doped Layered Double Hydroxide Nanorings as a Potential Imageable Drug Delivery System.Tumor-penetrating Peptide Conjugated and Doxorubicin Loaded T1-T2 Dual Mode MRI Contrast Agents Nanoparticles for Tumor Theranostics.Novel concept of the smart NIR-light-controlled drug release of black phosphorus nanostructure for cancer therapy.Molecular photosensitisers for two-photon photodynamic therapy.Dual-target cancer theranostic for glutathione S-transferase and hypoxia-inducible factor-1α inhibition.Supramolecular chemotherapy based on host-guest molecular recognition: a novel strategy in the battle against cancer with a bright future.Hexaphyrin as a Potential Theranostic Dye for Photothermal Therapy and 19 F Magnetic Resonance Imaging.Targeted combinational therapy inducing mitochondrial dysfunction.Activatable iRGD-based peptide monolith: Targeting, internalization, and fluorescence activation for precise tumor imaging.Intracellular Dual Fluorescent Lightup Bioprobes for Image-Guided Photodynamic Cancer Therapy.Defined Host-Guest Chemistry on Nanocarbon for Sustained Inhibition of Cancer.Polyrotaxane-based supramolecular theranostics.Big Potential from Small Agents: Nanoparticles for Imaging-Based Companion Diagnostics.One-pot method to prepare a theranostic nanosystem with magnetic resonance imaging function and anticancer activity through multiple mechanisms.Development of trackable metal-based drugs: new generation of therapeutic agents.A Versatile and Clearable Nanocarbon Theranostic Based on Carbon Dots and Gadolinium Metallofullerene Nanocrystals.Coumarin-appended phosphorescent cyclometalated iridium(iii) complexes as mitochondria-targeted theranostic anticancer agents.Somatostatin receptor-targeted organometallic iridium(iii) complexes as novel theranostic agents.A novel anticancer theranostic pro-prodrug based on hypoxia and photo sequential control.
P2860
Q30378401-C2468788-99B1-4966-A177-BC4E27086D45Q33686487-ED85CFAF-3554-4FCF-BB11-D7E3EC6784DEQ33812462-7B523BF1-CD01-427E-881F-0C02A3AF29A6Q36026841-20FDBB10-62AF-4297-92FB-469C2E376374Q36723759-5A335E45-AE03-41AE-9F77-041055A2589AQ37374114-4C4DE1D3-780A-4826-AEDC-E4CE3B5774C6Q37473897-B4494B07-19E2-497A-9717-30E1C2503526Q38673284-88C63A04-3F0F-4901-B880-738E4C36553BQ38682486-843EBFB6-D54C-457E-B77C-D1DBD961F72DQ38795345-52E5449A-9B13-4483-A188-EDC4886C50FEQ38814327-34FF10DC-4B50-4EB5-8060-171C82974CB9Q38827817-E03186E9-3EDB-44E7-BCCA-76756D3591FBQ38844453-866F45AE-D6BB-434F-A7EE-D79477202871Q38856643-9114D362-6550-448F-8328-516426738581Q39187880-33048A34-3829-405A-BA6B-05C16C9E3F09Q39216032-7E4902E0-0FE3-4ABA-9138-B0F4DB1116D3Q42263510-E49F5A44-8F1C-4CBC-91A8-5854A1FF5317Q42379306-CECB96CD-7C0C-448A-AA7D-B34B0D05416AQ42689349-62210093-65F0-4B93-807F-5C3DACE3A6B9Q43936819-1A2A3CD9-54CE-4204-B584-94D0AB5997ADQ46277986-BB39012D-F578-4842-B301-C885AE85544CQ47100910-2ABE62F7-09B2-468F-A071-4E9A44F14A6FQ47168995-59E4BF13-B994-440A-A515-A4E2754AF6D1Q47204043-C87AED7F-7B11-41E2-876E-56FDDFCAD6A7Q47370653-426E736B-D5E9-43A6-A5A8-56BA84C4F6E0Q47372909-E9A7C246-D20C-47B3-BF9D-C8FEB9DD698AQ47599299-A18F43E4-A171-45EE-B917-18A5CDA3EF7DQ48235253-2D22E5C0-EAF8-4E64-9C57-CBEA4C24FFBEQ48373789-2CE3BCEE-F651-4C45-AD90-41196D64A784Q49587716-412C7BA2-9136-4837-9E3B-08640F2405C7Q50200887-ABA1EF5F-16D6-4409-B222-838038EDF553Q50282362-AA958001-9C1D-41F5-845F-3F23ED6D1EC0Q50326915-2B775738-0F2E-4C72-BC83-B4A4EE724406Q50422486-F951EB1A-7523-47A4-99BF-B000570B0E56Q50676661-447FD582-2EB0-46D5-A719-ED4DEC94634CQ50856412-DAF775B2-70D9-4920-8B77-C85CD1F013D8Q51262828-B97446E8-DE85-4513-A164-32EE0C6A59EFQ51347617-D98AC93B-3BDB-44D0-A132-2BB6D1912EFBQ52662227-5491025D-9AC9-4254-A69E-4C21CFC5C3EAQ52981912-B2D19FA4-FE2C-4DA6-B8CE-6F214FA5D3B9
P2860
Small conjugate-based theranostic agents: an encouraging approach for cancer therapy.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Small conjugate-based theranostic agents: an encouraging approach for cancer therapy.
@en
type
label
Small conjugate-based theranostic agents: an encouraging approach for cancer therapy.
@en
prefLabel
Small conjugate-based theranostic agents: an encouraging approach for cancer therapy.
@en
P2093
P2860
P356
P1476
Small conjugate-based theranostic agents: an encouraging approach for cancer therapy
@en
P2093
Jong Seung Kim
Rajesh Kumar
Seyoung Koo
Weon Sup Shin
Won Young Kim
P2860
P304
P356
10.1039/C5CS00224A
P577
2015-10-01T00:00:00Z